tiprankstipranks
Trending News
More News >
Renheng Enterprise Holdings Limited (HK:3628)
:3628
Hong Kong Market

Renheng Enterprise Holdings Limited (3628) AI Stock Analysis

Compare
0 Followers

Top Page

HK:3628

Renheng Enterprise Holdings Limited

(3628)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
HK$0.22
▲(8.50% Upside)
Action:N/ADate:01/04/26
The score is driven primarily by strong financial stability (zero debt) and improved 2024 cash flow, offset by weaker 2024 operating performance (declining revenue and margin compression). Technicals are neutral-to-slightly bearish, while valuation looks reasonable based on the provided P/E.

Renheng Enterprise Holdings Limited (3628) vs. iShares MSCI Hong Kong ETF (EWH)

Renheng Enterprise Holdings Limited Business Overview & Revenue Model

Company DescriptionRENHENG Enterprise Holdings Limited, an investment holding company, manufactures and sells tobacco machinery products in the People's Republic of China. The company offers special-purpose tobacco machinery products, such as casing and flavoring systems, pneumatic feeding systems, and pre-pressing packing machines. The company was incorporated in 2011 and is headquartered in Admiralty, Hong Kong.
How the Company Makes Moneynull

Renheng Enterprise Holdings Limited Financial Statement Overview

Summary
Balance sheet strength is a major positive (essentially zero debt and solid equity), lowering financial risk. Profitability remains positive with healthy gross margins, but 2024 saw weaker results (revenue down ~10%, earnings down and net margin compressed to ~6% from ~11%). Cash flow rebounded strongly in 2024 with good earnings quality, though prior-year volatility keeps this from scoring higher.
Income Statement
56
Neutral
Profitability has improved versus earlier loss-making years, with 2024 remaining solidly profitable (about 6% net margin) and healthy gross margins in the mid-30% range. However, the trajectory weakened in 2024: revenue declined ~10% and earnings fell notably versus 2023, with margins compressing (net margin down from ~11% to ~6%). Overall, the business shows decent underlying margins but inconsistent growth and earnings volatility.
Balance Sheet
88
Very Positive
The balance sheet is a clear strength: debt is essentially zero across the period (including 2024 at zero), resulting in negligible leverage and strong financial flexibility. Equity is sizable and has been maintained, supporting a conservative risk profile. The main weakness is return on equity trending lower (roughly ~11% in 2023 down to ~5.5% in 2024), indicating the company is currently generating more modest profits relative to its equity base.
Cash Flow
62
Positive
Cash generation is mixed but improved materially in 2024, with operating cash flow and free cash flow both strongly positive and free cash flow roughly matching net income (good earnings quality). That said, cash flow has been volatile historically, including negative operating and free cash flow in 2022–2023, which raises questions about working-capital swings and consistency. Overall, 2024 is a strong rebound, but the track record is uneven.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue114.56M114.90M124.42M69.08M73.73M76.28M
Gross Profit45.31M38.53M45.72M25.57M28.28M29.84M
EBITDA16.24M12.38M17.11M-1.18M-688.00K4.33M
Net Income12.54M7.04M13.56M-2.36M721.00K-783.00K
Balance Sheet
Total Assets258.51M245.47M235.52M258.45M268.00M218.93M
Cash, Cash Equivalents and Short-Term Investments96.22M96.63M86.10M97.19M96.04M97.42M
Total Debt275.00K0.00212.00K0.00300.00K34.00K
Total Liabilities115.69M117.46M112.13M147.13M144.80M99.47M
Stockholders Equity142.83M128.01M123.39M111.32M123.20M119.46M
Cash Flow
Free Cash Flow10.59M19.81M-3.90M-7.88M10.13M22.18M
Operating Cash Flow10.71M19.98M-3.32M-7.21M10.64M23.70M
Investing Cash Flow-44.33M-44.94M-6.63M16.22M-10.19M-974.00K
Financing Cash Flow-211.00K-264.00K-264.00K-310.00K-4.61M-378.00K

Renheng Enterprise Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
HK$330.24M2.535.56%3.13%20.69%-24.85%
67
Neutral
HK$160.00M1.859.26%
66
Neutral
HK$595.00M2.778.36%3.34%-21.28%-29.40%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
53
Neutral
HK$113.09M37.78-14.84%19.32%-100.00%
51
Neutral
HK$363.56M-1.19-11.33%-0.51%-922.95%
39
Underperform
HK$478.84M-3.85-6.58%-4.33%55.43%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:3628
Renheng Enterprise Holdings Limited
0.20
0.08
65.83%
HK:1289
Wuxi Sunlit Science & Technology Co., Ltd. Class H
2.50
0.44
21.36%
HK:1536
Yuk Wing Group Holdings Ltd.
0.25
0.11
87.12%
HK:1673
Huazhang Technology Holding Ltd.
0.30
0.08
39.53%
HK:3302
Kinergy Corporation Ltd.
0.38
0.26
212.50%
HK:3348
China PengFei Group Limited
1.19
0.16
15.53%

Renheng Enterprise Holdings Limited Corporate Events

Renheng flags sharp profit rise on stronger margins and pneumatic system sales
Mar 9, 2026

Renheng Enterprise Holdings has issued a positive profit alert, indicating that unaudited profit before tax for the year ended 31 December 2025 is expected to rise to between HK$15 million and HK$18 million, up from HK$10 million a year earlier. Management attributes the improvement mainly to higher gross profit margins on non-standard customized equipment, helped by more favorable quotation strategies and bid structures.

The company also reported strong growth in its pneumatic feeding system business, whose share of total sales surged to at least about 17% in 2025 from 3% in 2024, signaling a meaningful shift in its revenue mix toward this product line. The board cautioned that the figures are based on unaudited management accounts and that final results, due by the end of March 2026, may differ, advising shareholders and potential investors to exercise care when trading the shares.

The most recent analyst rating on (HK:3628) stock is a Hold with a HK$0.21 price target. To see the full list of analyst forecasts on Renheng Enterprise Holdings Limited stock, see the HK:3628 Stock Forecast page.

Renheng Enterprise Sets March Board Meeting to Approve 2025 Annual Results
Mar 9, 2026

Renheng Enterprise Holdings Limited, a Cayman Islands-incorporated company listed in Hong Kong, is governed by a board comprising executive and independent non-executive directors. The board is chaired by Chief Executive Officer Liu Li, with its composition designed to balance management representation and independent oversight in line with market expectations for listed companies.

The company has scheduled a board meeting for 30 March 2026 to approve its annual results for the year ended 31 December 2025 and to consider recommending a final dividend. The timing signals that audited financials and potential shareholder returns will soon be disclosed, events that may influence investor sentiment and provide insight into the group’s recent operational and financial performance.

The meeting will also address other board business, underscoring the regular governance cycle typical for Hong Kong-listed firms ahead of annual reporting. For stakeholders, the announcement marks the start of the company’s formal year-end reporting process, which will clarify profitability, capital allocation decisions and any proposed distribution of earnings to shareholders.

The most recent analyst rating on (HK:3628) stock is a Hold with a HK$0.21 price target. To see the full list of analyst forecasts on Renheng Enterprise Holdings Limited stock, see the HK:3628 Stock Forecast page.

Renheng Enterprise Announces Resignation of Executive Director Wen Yuan
Feb 20, 2026

Renheng Enterprise Holdings Limited has announced a board change, with executive director Wen Yuan stepping down effective 20 February 2026 to concentrate on other business commitments. The company emphasized that Wen has no disagreements with the board and that no issues need to be brought to shareholders’ attention, while expressing gratitude for his contributions and confirming the remaining board composition.

The orderly transition signals continuity in the company’s governance and minimizes concerns over potential internal conflict or strategic disruption. Investors and other stakeholders are likely to view the resignation as a routine leadership adjustment, given the absence of cited disputes and the clear affirmation of stable management under Chairman and CEO Liu Li.

The most recent analyst rating on (HK:3628) stock is a Hold with a HK$0.21 price target. To see the full list of analyst forecasts on Renheng Enterprise Holdings Limited stock, see the HK:3628 Stock Forecast page.

Renheng Enterprise Details Board and Committee Structure
Feb 20, 2026

Renheng Enterprise Holdings Limited has announced the current composition of its board, naming Liu Li as chairman and chief executive officer alongside fellow executive director Lew Lai Kuen, with three independent non-executive directors providing oversight. The company has also detailed the membership and chairmanship of its audit, nomination and remuneration committees, underscoring its governance framework and role segregation in line with Hong Kong listing requirements.

Independent non-executive director Dr. Lam, Lee G. chairs the audit committee, while Mr. Cheung Kwong Tat leads the nomination committee and Mr. Lam Chi Wing heads the remuneration committee, each also serving as committee members where applicable. The clarified allocation of committee responsibilities signals the company’s emphasis on audit integrity, board appointment processes and remuneration oversight, offering greater transparency to shareholders and other stakeholders about its governance arrangements.

The most recent analyst rating on (HK:3628) stock is a Hold with a HK$0.21 price target. To see the full list of analyst forecasts on Renheng Enterprise Holdings Limited stock, see the HK:3628 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 04, 2026